Literature DB >> 26981193

Yersinia type III effectors perturb host innate immune responses.

Khavong Pha1, Lorena Navarro1.   

Abstract

The innate immune system is the first line of defense against invading pathogens. Innate immune cells recognize molecular patterns from the pathogen and mount a response to resolve the infection. The production of proinflammatory cytokines and reactive oxygen species, phagocytosis, and induced programmed cell death are processes initiated by innate immune cells in order to combat invading pathogens. However, pathogens have evolved various virulence mechanisms to subvert these responses. One strategy utilized by Gram-negative bacterial pathogens is the deployment of a complex machine termed the type III secretion system (T3SS). The T3SS is composed of a syringe-like needle structure and the effector proteins that are injected directly into a target host cell to disrupt a cellular response. The three human pathogenic Yersinia spp. (Y. pestis, Y. enterocolitica, and Y. pseudotuberculosis) are Gram-negative bacteria that share in common a 70 kb virulence plasmid which encodes the T3SS. Translocation of the Yersinia effector proteins (YopE, YopH, YopT, YopM, YpkA/YopO, and YopP/J) into the target host cell results in disruption of the actin cytoskeleton to inhibit phagocytosis, downregulation of proinflammatory cytokine/chemokine production, and induction of cellular apoptosis of the target cell. Over the past 25 years, studies on the Yersinia effector proteins have unveiled tremendous knowledge of how the effectors enhance Yersinia virulence. Recently, the long awaited crystal structure of YpkA has been solved providing further insights into the activation of the YpkA kinase domain. Multisite autophosphorylation by YpkA to activate its kinase domain was also shown and postulated to serve as a mechanism to bypass regulation by host phosphatases. In addition, novel Yersinia effector protein targets, such as caspase-1, and signaling pathways including activation of the inflammasome were identified. In this review, we summarize the recent discoveries made on Yersinia effector proteins and their contribution to Yersinia pathogenesis.

Entities:  

Keywords:  Effectors; Innate; Type III secretion; Virulence; Yersinia

Year:  2016        PMID: 26981193      PMCID: PMC4768113          DOI: 10.4331/wjbc.v7.i1.1

Source DB:  PubMed          Journal:  World J Biol Chem        ISSN: 1949-8454


  139 in total

Review 1.  The Yersinia Ysc-Yop 'type III' weaponry.

Authors:  Guy R Cornelis
Journal:  Nat Rev Mol Cell Biol       Date:  2002-10       Impact factor: 94.444

Review 2.  Type III protein secretion mechanism in mammalian and plant pathogens.

Authors:  Sheng Yang He; Kinya Nomura; Thomas S Whittam
Journal:  Biochim Biophys Acta       Date:  2004-11-11

Review 3.  NF-κB signaling pathways regulated by CARMA family of scaffold proteins.

Authors:  Marzenna Blonska; Xin Lin
Journal:  Cell Res       Date:  2010-12-28       Impact factor: 25.617

4.  RhoG regulates the neutrophil NADPH oxidase.

Authors:  Alison M Condliffe; Louise M C Webb; G John Ferguson; Keith Davidson; Martin Turner; Elena Vigorito; Maria Manifava; Edwin R Chilvers; Len R Stephens; Phillip T Hawkins
Journal:  J Immunol       Date:  2006-05-01       Impact factor: 5.422

5.  YopJ targets TRAF proteins to inhibit TLR-mediated NF-kappaB, MAPK and IRF3 signal transduction.

Authors:  Charles R Sweet; Joseph Conlon; Douglas T Golenbock; Jon Goguen; Neal Silverman
Journal:  Cell Microbiol       Date:  2007-06-30       Impact factor: 3.715

6.  Sequestering of Rac by the Yersinia effector YopO blocks Fcgamma receptor-mediated phagocytosis.

Authors:  Eleanor Groves; Katrin Rittinger; Marlise Amstutz; Sara Berry; David W Holden; Guy R Cornelis; Emmanuelle Caron
Journal:  J Biol Chem       Date:  2009-11-19       Impact factor: 5.157

7.  Modulation of T-cell activation by the glucocorticoid-induced leucine zipper factor via inhibition of nuclear factor kappaB.

Authors:  E Ayroldi; G Migliorati; S Bruscoli; C Marchetti; O Zollo; L Cannarile; F D'Adamio; C Riccardi
Journal:  Blood       Date:  2001-08-01       Impact factor: 22.113

8.  Characterization of the operon encoding the YpkA Ser/Thr protein kinase and the YopJ protein of Yersinia pseudotuberculosis.

Authors:  E E Galyov; S Håkansson; H Wolf-Watz
Journal:  J Bacteriol       Date:  1994-08       Impact factor: 3.490

9.  In vitro activation of murine peritoneal macrophages by recombinant YopJ: production of nitric oxide, proinflammatory cytokines and chemokines.

Authors:  Ajit Sodhi; Ashok Kumar Pandey
Journal:  Immunobiology       Date:  2010-08-19       Impact factor: 3.144

10.  Identification of residues in the N-terminal domain of the Yersinia tyrosine phosphatase that are critical for substrate recognition.

Authors:  L G Montagna; M I Ivanov; J B Bliska
Journal:  J Biol Chem       Date:  2000-11-07       Impact factor: 5.157

View more
  22 in total

1.  Redundant and Cooperative Roles for Yersinia pestis Yop Effectors in the Inhibition of Human Neutrophil Exocytic Responses Revealed by Gain-of-Function Approach.

Authors:  Amanda R Pulsifer; Aruna Vashishta; Shane A Reeves; Jennifer K Wolfe; Samantha G Palace; Megan K Proulx; Jon Goguen; Sobha R Bodduluri; Bodduluri Haribabu; Silvia M Uriarte; Matthew B Lawrenz
Journal:  Infect Immun       Date:  2020-02-20       Impact factor: 3.441

Review 2.  Immunomodulatory Yersinia outer proteins (Yops)-useful tools for bacteria and humans alike.

Authors:  Benjamin Grabowski; M Alexander Schmidt; Christian Rüter
Journal:  Virulence       Date:  2017-03-15       Impact factor: 5.882

3.  Synthetic Cyclic Peptomers as Type III Secretion System Inhibitors.

Authors:  Hanh Lam; Joshua Schwochert; Yongtong Lao; Tannia Lau; Cameron Lloyd; Justin Luu; Olivia Kooner; Jessica Morgan; Scott Lokey; Victoria Auerbuch
Journal:  Antimicrob Agents Chemother       Date:  2017-08-24       Impact factor: 5.191

4.  Characterization of Pyrin Dephosphorylation and Inflammasome Activation in Macrophages as Triggered by the Yersinia Effectors YopE and YopT.

Authors:  Natasha P Medici; Maheen Rashid; James B Bliska
Journal:  Infect Immun       Date:  2019-02-21       Impact factor: 3.441

5.  Gain-of-Function Analysis Reveals Important Virulence Roles for the Yersinia pestis Type III Secretion System Effectors YopJ, YopT, and YpkA.

Authors:  Samantha G Palace; Megan K Proulx; Rose L Szabady; Jon D Goguen
Journal:  Infect Immun       Date:  2018-08-22       Impact factor: 3.441

6.  Pseudomonas aeruginosa Enolase Influences Bacterial Tolerance to Oxidative Stresses and Virulence.

Authors:  Yuding Weng; Fei Chen; Yiwei Liu; Qiang Zhao; Ronghao Chen; Xiaolei Pan; Chang Liu; Zhihui Cheng; Shouguang Jin; Yongxin Jin; Weihui Wu
Journal:  Front Microbiol       Date:  2016-12-15       Impact factor: 5.640

7.  Yersinia pestis escapes entrapment in thrombi by targeting platelet function.

Authors:  Samantha G Palace; Olga Vitseva; Megan K Proulx; Jane E Freedman; Jon D Goguen; Milka Koupenova
Journal:  J Thromb Haemost       Date:  2020-09-20       Impact factor: 5.824

8.  LcrQ Coordinates with the YopD-LcrH Complex To Repress lcrF Expression and Control Type III Secretion by Yersinia pseudotuberculosis.

Authors:  Keke Fei; Huan Yan; Xiaoyan Zeng; Shaojia Huang; Wei Tang; Matthew S Francis; Shiyun Chen; Yangbo Hu
Journal:  mBio       Date:  2021-06-22       Impact factor: 7.867

9.  Hereditary Hemochromatosis Predisposes Mice to Yersinia pseudotuberculosis Infection Even in the Absence of the Type III Secretion System.

Authors:  Halie K Miller; Leah Schwiesow; Winnie Au-Yeung; Victoria Auerbuch
Journal:  Front Cell Infect Microbiol       Date:  2016-06-24       Impact factor: 5.293

10.  Loss of CNFY toxin-induced inflammation drives Yersinia pseudotuberculosis into persistency.

Authors:  Wiebke Heine; Michael Beckstette; Ann Kathrin Heroven; Sophie Thiemann; Ulrike Heise; Aaron Mischa Nuss; Fabio Pisano; Till Strowig; Petra Dersch
Journal:  PLoS Pathog       Date:  2018-02-01       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.